Vigabatrin (γ-Vinyl-GABA) is an orally active, irreversible inhibitor of GABA transaminase, increasing brain GABA levels by blocking its breakdown. It is an antiepileptic drug that enhances inhibitory neurotransmission to control seizures and exhibits potential in treating partial seizures, infantile spasms, and Lennox-Gastaut syndrome.